Disulergine

Last updated

Disulergine
Disulergine structure.png
Clinical data
Other namesCH-29717; CH 29-717; Sulergine; N,N-Dimethyl-N'-(6-methylergoline-8α-yl)sulfamide
Drug class Dopamine agonist; Prolactin inhibitor
Identifiers
  • (6aR,9S,10aR)-9-(dimethylsulfamoylamino)-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
Formula C17H24N4O2S
Molar mass 348.47 g·mol−1
3D model (JSmol)
  • CN1C[C@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)NS(=O)(=O)N(C)C
  • InChI=1S/C17H24N4O2S/c1-20(2)24(22,23)19-12-8-14-13-5-4-6-15-17(13)11(9-18-15)7-16(14)21(3)10-12/h4-6,9,12,14,16,18-19H,7-8,10H2,1-3H3/t12-,14+,16+/m0/s1
  • Key:VUEGYUOUAAVYAS-JGGQBBKZSA-N

Disulergine (INN Tooltip International Nonproprietary Name; developmental code names CH-29717 or CH 29-717) is a dopamine agonist of the ergoline family described as a prolactin inhibitor which was never marketed. [1] [2] [3] [4] It is known to be a metabolite of mesulergine. [5] [6] The drug was first described in the literature by 1976. [1] [3]

See also

References

  1. 1 2 Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. ISBN   978-1-4757-2085-3 . Retrieved 30 June 2025.
  2. ↑ Symposium NN (1986). The Neurobiology of Dopamine Systems. Manchester University Press. ISBN   978-0-7190-1799-5 . Retrieved 30 June 2025.
  3. 1 2 Flückiger E, Briner U, Doepfner W, Kovacs E, Marbach P, Wagner HR (October 1978). "Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171". Experientia. 34 (10): 1330–1332. doi:10.1007/BF01981452. PMID   570121.
  4. ↑ Markó M (June 1984). "Dopamine agonistic potency of two novel prolactin release-inhibiting ergolines". European Journal of Pharmacology. 101 (3–4): 263–266. doi:10.1016/0014-2999(84)90167-5. PMID   6468500.
  5. ↑ Baas H, Schneider E, Fischer PA, Japp G (1985). "Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism". Journal of Neural Transmission. 64 (1): 45–54. doi:10.1007/BF01259344. PMID   4067602.
  6. ↑ Enz A, Donatsch P, Nordmann R (1984). "Dopaminergic properties of mesulergine (CU 32-085) and its metabolites". Journal of Neural Transmission. 60 (3–4): 225–238. doi:10.1007/BF01249095. PMID   6527137.



This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.